Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
Sign Up
Log in

ENDRA Life Sciences Inc
NASDAQ:NDRA

Watchlist Manager
ENDRA Life Sciences Inc Logo
ENDRA Life Sciences Inc
NASDAQ:NDRA
Watchlist
Price: 3.27 USD -3.25% Market Closed
Market Cap: $3.8m
Write Note Create Alert Ask AI

Relative Value

NDRA doesn't have a meaningful market cap.

The Relative Value of one NDRA stock under the Base Case scenario is 0.14 USD. Compared to the current market price of 3.27 USD, ENDRA Life Sciences Inc is Overvalued by 96%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NDRA Relative Value
Base Case
0.14 USD
Overvaluation 96%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

P/S
View Details
P/E
View Details
P/OCF
View Details
P/FCFE
View Details
P/B
View Details
EV/S
View Details
EV/GP
View Details
EV/EBITDA
View Details
EV/EBIT
View Details
EV/OCF
View Details
EV/FCFF
View Details
EV/IC
View Details

Multiples Across Competitors

NDRA Competitors Multiples
ENDRA Life Sciences Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
ENDRA Life Sciences Inc
NASDAQ:NDRA
3.8m USD 0 -0.5 -0.4 -0.4
US
Abbott Laboratories
NYSE:ABT
187.6B USD 4.2 28.8 16.5 22.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
167.7B USD 16.7 58.7 44.5 54.7
US
Stryker Corp
NYSE:SYK
128.8B USD 5.1 39.7 20.3 24.5
IE
Medtronic PLC
NYSE:MDT
112B USD 3.2 24.2 13.4 19.5
US
Boston Scientific Corp
NYSE:BSX
102.5B USD 5.1 35.4 20.8 27.9
DE
Siemens Healthineers AG
XETRA:SHL
43.9B EUR 1.9 20.7 11.5 16.2
US
Edwards Lifesciences Corp
NYSE:EW
47.7B USD 7.8 44.3 24.3 26.6
US
Becton Dickinson and Co
NYSE:BDX
45.8B USD 2.1 25.8 10.2 17.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
45.5B USD 10.6 43.2 30.7 34
US
Resmed Inc
NYSE:RMD
33.7B USD 6.2 22.6 15.9 17.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
ENDRA Life Sciences Inc
NASDAQ:NDRA
Average EV/EBITDA: 20.8
Negative Multiple: -0.4 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
16.5
11%
1.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
44.5
23%
1.9
US
Stryker Corp
NYSE:SYK
20.3
12%
1.7
IE
Medtronic PLC
NYSE:MDT
13.4
8%
1.7
US
Boston Scientific Corp
NYSE:BSX
20.8
18%
1.2
DE
Siemens Healthineers AG
XETRA:SHL
11.5
10%
1.2
US
Edwards Lifesciences Corp
NYSE:EW
24.3
14%
1.7
US
Becton Dickinson and Co
NYSE:BDX
10.2
1%
10.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
30.7
11%
2.8
US
Resmed Inc
NYSE:RMD
15.9
11%
1.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
ENDRA Life Sciences Inc
NASDAQ:NDRA
Average EV/EBIT: 26.1
Negative Multiple: -0.4 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
22.6
18%
1.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
54.7
25%
2.2
US
Stryker Corp
NYSE:SYK
24.5
16%
1.5
IE
Medtronic PLC
NYSE:MDT
19.5
17%
1.1
US
Boston Scientific Corp
NYSE:BSX
27.9
26%
1.1
DE
Siemens Healthineers AG
XETRA:SHL
16.2
15%
1.1
US
Edwards Lifesciences Corp
NYSE:EW
26.6
15%
1.8
US
Becton Dickinson and Co
NYSE:BDX
17.2
15%
1.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
34
12%
2.8
US
Resmed Inc
NYSE:RMD
17.7
12%
1.5

See Also

Summary
NDRA intrinsic value, competitors valuation, and company profile.
DCF Valuation
NDRA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NDRA stock valuation using valuation multiples.
Wall Street Estimates
NDRA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NDRA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 323,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett